Details for New Drug Application (NDA): 016680
✉ Email this page to a colleague
NDA 016680 describes EUTHROID-3, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the EUTHROID-3 profile page.
The generic ingredient in EUTHROID-3 is liotrix (t4;t3). Additional details are available on the liotrix (t4;t3) profile page.
The generic ingredient in EUTHROID-3 is liotrix (t4;t3). Additional details are available on the liotrix (t4;t3) profile page.
Summary for 016680
| Tradename: | EUTHROID-3 |
| Applicant: | Parke Davis |
| Ingredient: | liotrix (t4;t3) |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.03MG;0.0075MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.06MG;0.015MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.12MG;0.03MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
